You just read:

Augie's Quest Reports First Subject Successfully Enrolled in AT-1501 Phase 1 Study, a First-of-its-Kind, Promising Treatment for ALS

News provided by

Augie’s Quest to Cure ALS

Nov 28, 2018, 11:00 ET